GUARANTYGuaranty • March 19th, 2010 • Corgenix Medical Corp/Co • In vitro & in vivo diagnostic substances
This Guaranty (“Agreement”) is made and executed this day of March, 2010 by Corgenix Incorporated, a corporation, duly incorporated and validly existing pursuant to the laws of Delaware (“Guarantor”), having its principal place of business at 11575 Main Street, Broomfield, CO, in favor of FAUNUS GROUP INTERNATIONAL, INC., a Delaware corporation (“FGI”), having its principal place of business at 80 Broad Street, 22nd Floor, New York, New York 10004.
DEBENTURE (CLIENT) (including mortgage over plant, machinery and equipment)Debenture • March 19th, 2010 • Corgenix Medical Corp/Co • In vitro & in vivo diagnostic substances • England and Wales
DATED of March 2010 RECEIVABLES FINANCE AGREEMENTReceivables Finance Agreement • March 19th, 2010 • Corgenix Medical Corp/Co • In vitro & in vivo diagnostic substances
The clause headings used in this Agreement are for guidance only and are not intended to affect its interpretation. These general conditions must be read in conjunction with any agreement of which they are expressed to form part. A list of general definitions can be found in Clause 25.
Intercreditor AgreementIntercreditor Agreement • March 19th, 2010 • Corgenix Medical Corp/Co • In vitro & in vivo diagnostic substances
This Intercreditor Agreement is made and entered into between Summit Financial Resources, L.P., a Hawaii limited partnership (“Summit”), and Faunus Group International, Inc., a Delaware corporation (“FGI”), and is acknowledged and consented to by CORGENIX MEDICAL CORPORATION, a Nevada corporation, and CORGENIX, INC., a Delaware corporation (collectively, and jointly and severally, “US Client”) and CORGENIX UK LTD. (“UK Client”).
